Clinical Trials · NCT07297238

Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

Name: Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ASemaglutide

Phase: N/A
Recruitment status: Completed
Sponsor: Jinling Hospital, China
Enrollment: 20
Start date: Jan 2026
Locations: 2 sites, China
Primary endpoint: Serum Biomarkers of Intestinal Barrier Function

View Semaglutide compound reference